Table 2.

the main laboratory findings of sarcodiosis population dividing according to GenPhenReSa classification. All data were expressed as median IQR. (1. P=0.0191)

Laboratory findings	All patients n=129	Pulmonary and intrathoracic lymph node n=86	Ocular-cardiac-cutaneous-CNS n=17	Abdominal n=16	Musculoskeletal-cutaneous n=10
ACE (U/l)	47 (37-65)	49 (39-70)	45 (35-50)	58 (31-65)	39 (35-46)
CRP (mg/dl)	0.3 (0.16-0.71)	0.28 (0.14-0.74)	0.34 (0.23-0.71)	0.19 (0.13-0.56)	0.21 (0.08-0.36)
Hb (g/dl)	13.9 (12.9-15.1)	14 (13.1-15.1)	13.5 (11.7-15)	14.1 (12.4-14.6)	13.7 (12.7-14.9)
WBC (x103/µl)	6.4 (5.2-8.0)	6.5 (5.5-8.0)	5.9 (4.9-7.6)	5.3 (4.8-7.6)	6.6 (5.7-8.1)
Neutrophils (x103/µl)	3.6 (2.8-5.1)	3.8 (3.0-5.2)	3.5 (3.1-4.8)	3.2 (2.6-4.6)	4.2 (3.2-4.9)
Lymphocytes (x103/µl)	1.7 (1.1-2.2)	1.7 (1.2-2.4)	1.9 (1.4-2.1)	1.4 (0.9-1.9)	1.7 (1.1-2.1)
Monocytes (x103/µl)	0.6 (0.5-0.7)	0.6 (0.5-0.7)	0.52 (0.46-0.54)1	0.63 (0.51-0.72)1	0.59 (0.58-0.66)
Eosinophils (x103/µl)	0.15 (0.09-0.21)	0.15 (0.09-0.21)	0.14 (0.10-0.18)	0.23 (0.11-0.72)	0.15 (0.12-0.21)
Neutrophil (%)	62.2 (53.9-67.4)	62.5 (54.1-67.4)	62.4 (53.1-66.8)	59.4 (54.4-65.2)	62.9 (55-66.8)
Lymphocites (%)	25.7 (19.3-33.1)	25.7 (19.5-31)	27.6 (21.2-34.7)	24.7 (18.8-29.1)	25.1 (19-30.3)
N/L ratio	2.4 (1.6-3.4)	2.4 (1.8-3.4)	2.3 (1.5-3.1)	2.4 (1.9-3.6)	2.45 (1.87-3.53)
Monocytes (%)	9.1 (7.7-10.9)	9.2 (7.7-10.8)	8.0 (7.5-9.2)	11.2 (8.4-12.1)	10.2 (7.9-11)
Eosinophils (%)	2.3 (1.6-3.4)	2.3 (1.6-3.3)	2.1 (1.5-3.2)	4.1 (2.4-8.1)	2.5 (1.9-3)
PLT (x103/µl)	240 (210-283)	242 (212-278)	258 (222-305)	208 (191-301)	217 (212-256)
Creatinine (mg/dl)	0.85 (0.74-0.99)	0.89 (0.76-1.01)	0.77 (0.73-0.83)	0.97 (0.85-1.06)	0.81 (0.69-0.98)
Total Bilirubin (mg/dl)	0.5 (0.4-0.6)	0.5 (0.4-0.6)	0.5 (0.4-0.7)	0.45 (0.4-0.52)	0.4 (0.3-0.4)
SGOT (U/l)	19.5 (15-24)	19 (15-23)	21 (18-25)	17.5 (12.5-20.2)	15 (14-21)
SGPT (U/l)	18 (14-25)	18 (14-25)	18 (14-30)	14.5 (9.2-24.5)	15 (15-20)